Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)

Detalles Bibliográficos
Autores principales: Flora, Akshay, Holland, Richard, Smith, Annika, Frew, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255171/
https://www.ncbi.nlm.nih.gov/pubmed/34258349
http://dx.doi.org/10.1016/j.jdcr.2021.05.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255171/
https://www.ncbi.nlm.nih.gov/pubmed/34258349
http://dx.doi.org/10.1016/j.jdcr.2021.05.029

Ejemplares similares